COMPOUND USED AS KINASE INHIBITOR AND USE THEREOF
The present invention belongs to the field of synthesis of heterocyclic compound drugs with a nitrogen atom as a heterocyclic atom; particularly relates to a compound used as a kinase inhibitor and the use thereof; and also relates to the preparation of a free base crystal form of the compound. The...
Saved in:
| Main Authors | , , , , |
|---|---|
| Format | Patent |
| Language | English |
| Published |
11.07.2024
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention belongs to the field of synthesis of heterocyclic compound drugs with a nitrogen atom as a heterocyclic atom; particularly relates to a compound used as a kinase inhibitor and the use thereof; and also relates to the preparation of a free base crystal form of the compound. The compound used as a kinase inhibitor is a compound as shown in formula 1, or a deuterated compound thereof, or a pharmaceutically acceptable salt, solvate or prodrug. Biological activity experiments prove that the above compound has a good inhibitory activity on exon 20 insertion mutations in EGFR and Her2, exon 19 deletion in EGFR and exon 21 point mutation in EGFR, and can be used as the bulk drug in relevant drugs. |
|---|---|
| AbstractList | The present invention belongs to the field of synthesis of heterocyclic compound drugs with a nitrogen atom as a heterocyclic atom; particularly relates to a compound used as a kinase inhibitor and the use thereof; and also relates to the preparation of a free base crystal form of the compound. The compound used as a kinase inhibitor is a compound as shown in formula 1, or a deuterated compound thereof, or a pharmaceutically acceptable salt, solvate or prodrug. Biological activity experiments prove that the above compound has a good inhibitory activity on exon 20 insertion mutations in EGFR and Her2, exon 19 deletion in EGFR and exon 21 point mutation in EGFR, and can be used as the bulk drug in relevant drugs. |
| Author | WU, Yusheng LIANG, Apeng LI, Jun NIU, Chengshan GUO, Zhongwei |
| Author_xml | – fullname: NIU, Chengshan – fullname: GUO, Zhongwei – fullname: WU, Yusheng – fullname: LIANG, Apeng – fullname: LI, Jun |
| BookMark | eNrjYmDJy89L5WQwdPb3DfAP9XNRCA12dVFwDFbw9vRzDHZV8PTz8HTyDPEPUnCESCqEeLgGufq78TCwpiXmFKfyQmluBmU31xBnD93Ugvz41OKCxOTUvNSSeMdQIwMjYyMTMxMDU0dDY-JUAQDP_ijY |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | AU2023246405A1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_AU2023246405A13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Oct 11 05:30:04 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_AU2023246405A13 |
| Notes | Application Number: AU20230246405 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240711&DB=EPODOC&CC=AU&NR=2023246405A1 |
| ParticipantIDs | epo_espacenet_AU2023246405A1 |
| PublicationCentury | 2000 |
| PublicationDate | 20240711 |
| PublicationDateYYYYMMDD | 2024-07-11 |
| PublicationDate_xml | – month: 07 year: 2024 text: 20240711 day: 11 |
| PublicationDecade | 2020 |
| PublicationYear | 2024 |
| RelatedCompanies | TYK MEDICINES, INC TYK MEDICINES (ZHENGZHOU), INC |
| RelatedCompanies_xml | – name: TYK MEDICINES (ZHENGZHOU), INC – name: TYK MEDICINES, INC |
| Score | 3.5576367 |
| Snippet | The present invention belongs to the field of synthesis of heterocyclic compound drugs with a nitrogen atom as a heterocyclic atom; particularly relates to a... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | COMPOUND USED AS KINASE INHIBITOR AND USE THEREOF |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240711&DB=EPODOC&locale=&CC=AU&NR=2023246405A1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlIDSt-K6xto-DOlHSiu0HWsrexv9hIF0w1X8973ETve0t5CDS3JwuftdcncAjyqlZW3olaxxuEpzo5D17KWUC6POx2WNBlf8qgxCzUvp2_x53oOPbS6MqBP6LYojokYVqO-tuK_X_0EsR_yt3DzlS5xavbrJxJE6dCzgiSI51oRNIyeyJdtGJCmFM05D10FD98RErHTAHWleaZ-9WzwvZb1rVNxTOJwiv6Y9g17VDODY3vZeG8BR0D1547DTvs05KHYUTKM0dEgaM4eYMUHsbcaM-KHnW34SzYj5SySJx2Ysci_gwWWJ7cm49uLvqAsz3d2oegn9ZtVUV0CyAnHsmHfQK1WqlrmulsaoLiqqjWiGTt01DPdxutlPvoUTLjwes1SUIfTbz6_qDo1tm98LGf0AmvB8SQ |
| link.rule.ids | 230,309,786,891,25594,76903 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfZ3dS8MwEMCPMcX5plNxOjWg9K24rrFrH4b0k1bXdqyt7K30EwTphqv473uNne5pbyEHlw-43P2SXALwIFKal4pc8FKDqzRVMl5OJjmfKWU6zkt0uOxWpetJdkRflk_LDnxsc2HYO6Hf7HFEtKgM7b1m6_X6fxPLYHcrN4_pO1atnq1wanAtHTM8EThDm5pz3_B1TteRJDlv0cgwdJAwPFGRlQ4mCIUMlt60Ji9lvetUrBM4nKO-qj6FTlH1oadv_17rw5HbHnljsbW-zRkIuu_O_cgzSBSYBlEDguytBiZxPNvRnNBfEPVXSELbXJi-dQ73lhnqNo9tx39DjdVot6PiBXSrVVVcAkky5Nhx84NeLlIxT2UxV0ZlVlBpRBMM6gYw3Kfpar_4Dnp26M7imeO9XsNxM5HN_qUgDKFbf34VN-h46_SWzdcPj4Z_Mw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COMPOUND+USED+AS+KINASE+INHIBITOR+AND+USE+THEREOF&rft.inventor=NIU%2C+Chengshan&rft.inventor=GUO%2C+Zhongwei&rft.inventor=WU%2C+Yusheng&rft.inventor=LIANG%2C+Apeng&rft.inventor=LI%2C+Jun&rft.date=2024-07-11&rft.externalDBID=A1&rft.externalDocID=AU2023246405A1 |